mAbs (University of Tennessee)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NamemAbs (University of Tennessee)
Drug Alias Namefibrin-dependent plasminogen activation inhibitors (University of Tennessee)TPAi-14TPAi-23
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionFibrinolysis inhibitorsPlasminogen inhibitors
TargetsPlasminogen
Therapy Area/IndicationsHemorrhage
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe University Of Tennessee
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity of Tennessee Research Foundation Office of Technology TransferThe University Of Tennessee
Active IndicationsN/A
Inactive IndicationsHemorrhage

Other Information

ATC CodeN/A
Related LinksN/A